Skip to main content
. 2021 Nov 19;21:1247. doi: 10.1186/s12885-021-08983-2

Fig. 1.

Fig. 1

Oligo-residual disease and PD limited to residual sites. The criteria and legends for Oligo-residual disease. EGFR, epidermal growth factor receptor; PD, progressive disease; TKI, tyrosine kinase inhibitor